Search Results

Darunavir Ethanolate 25 mg  | Purity Not Available

TargetMol

Darunavir ethanolate is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.

More Information Supplier Page

Darunavir Ethanolate 10 mg  | Purity Not Available

TargetMol

Darunavir ethanolate is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.

More Information Supplier Page

YM-90709 5 mg  | 99.67%

TargetMol

YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.

More Information Supplier Page

YM-90709 50 mg  | 99.67%

TargetMol

YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.

More Information Supplier Page

YM-90709 25 mg  | 99.67%

TargetMol

YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.

More Information Supplier Page

YM-90709 10 mg  | 99.67%

TargetMol

YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.

More Information Supplier Page

KM11060 100 mg  | 99.67%

TargetMol

KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.

More Information Supplier Page

KM11060 10 mg  | 99.67%

TargetMol

KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.

More Information Supplier Page